Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $4.34 Million - $5.08 Million
-68,503 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$68.67 - $84.02 $571,403 - $699,130
-8,321 Reduced 10.83%
68,503 $4.71 Million
Q2 2021

Aug 16, 2021

BUY
$79.87 - $87.53 $2.15 Million - $2.36 Million
26,945 Added 54.02%
76,824 $6.47 Million
Q1 2021

May 17, 2021

BUY
$76.02 - $100.5 $191,570 - $253,260
2,520 Added 5.32%
49,879 $4.05 Million
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $59,343 - $71,809
-735 Reduced 1.53%
47,359 $4.11 Million
Q3 2020

Nov 12, 2020

SELL
$85.07 - $109.69 $1.31 Million - $1.69 Million
-15,398 Reduced 24.25%
48,094 $4.2 Million
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $4.39 Million - $6.44 Million
-59,142 Reduced 48.23%
63,492 $6.51 Million
Q1 2020

May 13, 2020

SELL
$63.18 - $85.97 $624,218 - $849,383
-9,880 Reduced 7.46%
122,634 $8.85 Million
Q4 2019

Feb 13, 2020

BUY
$73.04 - $95.72 $1.86 Million - $2.43 Million
25,418 Added 23.73%
132,514 $11.7 Million
Q3 2019

Nov 13, 2019

BUY
$72.82 - $86.52 $1.37 Million - $1.63 Million
18,782 Added 21.27%
107,096 $7.8 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $1.96 Million - $2.37 Million
26,669 Added 43.26%
88,314 $7.48 Million
Q1 2019

May 15, 2019

SELL
$63.56 - $88.17 $59,110 - $81,998
-930 Reduced 1.49%
61,645 $5.28 Million
Q4 2018

Feb 13, 2019

BUY
$58.5 - $69.94 $899,203 - $1.08 Million
15,371 Added 32.56%
62,575 $3.9 Million
Q3 2018

Nov 13, 2018

SELL
$61.75 - $74.23 $39,087 - $46,987
-633 Reduced 1.32%
47,204 $3.26 Million
Q1 2018

May 15, 2018

SELL
$83.06 - $100.98 $411,230 - $499,951
-4,951 Reduced 9.38%
47,837 $4.06 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $1.8 Million - $2.25 Million
-19,288 Reduced 26.76%
52,788 $5 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $54,575 - $69,135
500 Added 0.7%
72,076 $8.41 Million
Q2 2017

Aug 14, 2017

BUY
N/A
71,576
71,576 $9.22 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.